National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

NCCN and Lilly Quality of Care in Gastric Cancer Opportunity: Submit by October 24, 2018

National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it is collaborating with Eli Lilly and Company (Lilly) to offer a new opportunity seeking proposals to bridge gaps in care for gastric and gastroesophageal junction (GEJ) cancer patients in the United States. The Request for Proposals (RFP) clearly outlines the scope and process that will be followed for the submission of Letters of Intent (LOIs). 

The intent of the RFP is to encourage US organizations to submit LOIs describing concepts and ideas for developing, implementing and evaluating programs that close clinical practice gaps and improve the quality of care for patients with gastric/GEJ cancer through adherence to evidence-based medicine guidelines, and improved competence and performance of healthcare providers and healthcare systems.

NCCN views this collaboration with Lilly as clear recognition of the advantages offered to industry and organizations treating cancer patients through the NCCN Oncology Research Program. We hope you and your colleagues will be interested in this opportunity.

LOIs are due by 11:59 PM EDT, Wednesday, October 24, 2018. If you have any questions regarding this RFP, please direct them in writing to Nicole Kamienski at with the subject line, “2018 Gastric Project.”

View RFP